FOUR-YEAR OUTCOMES AFTER INTRAVITREAL AFLIBERCEPT FOR MACULAR NEOVASCULARIZATION IN PATIENTS WITH PATHOLOGIC MYOPIA
Intravitreal aflibercept therapy with the pro re nata regimen provides a 4-year visual benefit in eyes with myopic macular neovascularization, and it is better than the reported natural course in maintaining the best-corrected visual acuity.
Authors
- Natsuko Nagaoka (ORCID: https://orcid.org/0000-0002-2192-6027)
- Kengo Uramoto
- Kyoko Ohno‐Matsui (ORCID: https://orcid.org/0000-0002-8375-6879)
- Tae Igarashi
- Yuichiro Kaneko (ORCID: https://orcid.org/0000-0002-6369-1115)
- Takeshi Yoshida (ORCID: https://orcid.org/0000-0002-0520-0656)
- Yuka Mizuno-Onishi
Institutions
- Institute of Science Tokyo (JP)
Publication Details
- Journal
- Retina
- Published
- 2024-11-27
- DOI
- https://doi.org/10.1097/iae.0000000000004341
- Citations
- 1
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.54